European Stroke Prevention Study-2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation?

Author： Picano E. Abbracchio M.P.

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.19, Iss.1, 1998-01, pp. : 14-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Astrocytes: Targets for Neuroprotection in Stroke

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 164-173

Bentham Science Publishers

Access to resources Recommend Favorite

Candesartan for the prevention and treatment of stroke – results of the SCOPE and ACCESS trials

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 687-690

Informa Healthcare

Access to resources Recommend Favorite

What can Adenosine Neuromodulation do for Neuroprotection?

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 325-329

Bentham Science Publishers

Access to resources Recommend Favorite

Endogenous adenosine prevents post-tetanic release facilitation mediated by 3 2 nicotinic autoreceptors

By Timoteo M.A. Faria M. Correia-de-Sa P.

European Journal of Pharmacology, Vol. 464, Iss. 2, 2003-03 ,pp. : 115-125

Elsevier

Access to resources Recommend Favorite

Adenosine A 2 receptors modulate haloperidol-induced catalepsy in rats - VII: Adenosine receptors

By Mandhane S.N. Chopde C.T. Ghosh A.K.

European Journal of Pharmacology, Vol. 328, Iss. 2, 1997-09 ,pp. : 135-141

Elsevier

Access to resources Recommend Favorite